Squalene and sterol carrier protein of liver plays a general role as a vehicle for cholesterol and its water-insoluble precursors; the carrier protein is essential for enzymic cholesterol synthesis. Liver microsomal enzymes contain a small amount of endogenous carrier protein, which is readily removed by washing or purification of the enzyme. Enzymic conversion to products of a cholesterol precursor carrier protein complex is markedly faster than that for initially unbound sterol. The protomer form of the carrier protein has a molecular weight of 16,000; during sodium dodecyl sulfate gel electrophoresis one band is observed. Phospholipid facilitates the aggregation of the protomer to the oligomer form (>150,000 daltons; purified 720-fold) accompanied by the binding of cholesterol precursors to the oligomer. The carrier protein binds fatty acids as well as cholesterol precursors, suggesting that it may more generally be a lipid carrier protein with "squalene and sterol carrier protein" describing the functional aspects of the lipid carrier in cholesterol biosynthesis. Studies with several steroids and related compounds revealed that the binding sites of lipid carrier protein must contain highly specific hydrophobic and polar regions.
enzymes contain a small amount of endogenous carrier protein, which is readily removed by washing or purification of the enzyme. Enzymic conversion to products of a cholesterol precursor carrier protein complex is markedly faster than that for initially unbound sterol. The protomer form of the carrier protein has a molecular weight of 16,000; during sodium dodecyl sulfate gel electrophoresis one band is observed. Phospholipid facilitates the aggregation of the protomer to the oligomer form (>150,000 daltons; purified 720-fold) accompanied by the binding of cholesterol precursors to the oligomer. The carrier protein binds fatty acids as well as cholesterol precursors, suggesting that it may more generally be a lipid carrier protein with "squalene and sterol carrier protein" describing the functional aspects of the lipid carrier in cholesterol biosynthesis. Studies with several steroids and related compounds revealed that the binding sites of lipid carrier protein must contain highly specific hydrophobic and polar regions.
Earlier we reported that squalene and sterol carrier protein (SCP), a heat-stable protein found in the soluble fraction of liver homogenates, is essential for optimum conversion of water-insoluble precursors to cholesterol by microsomal enzymes (1) (2) (3) (4) (5) (6) (7) (8) . Aspects of these findings were confirmed by other laboratories, (e.g., refs. 9 and 10). In the two previous articles of this series (5, 6) , we also presented evidence that: (i) SCP specifically binds squalene and sterol intermediates, (ii) a noncovalent squalene or sterol* SCP complex (oligomer, >150,000 daltons) appears to form part of the active site of each microsomal enzyme in cholesterol biosynthesis, and (iii) an SCP-like molecule is a component of the high-density lipoprotein fraction of serum. More recently we demonstrated the occurrence of an SCP-like molecule in adrenal preparations catalyzing the initial steps of cholesterol metabolism to steroid hormones (11) . Accordingly, we proposed that SCP functions uniquely as a vehicle for water-insoluble precursors during cholesterol biosynthesis and that SCP or a structurally similar protein participates in the transport and metabolism of cholesterol (5, 11) .
In this communication we describe the absolute requirement for SCP by microsomal enzymes, effects on conversion Addreviations: SCP, squalene and sterolcarrier protein; SDS, sodium dodecyl sulfate. * To whom requests for reprints should be addressed. This paper is no. III of a series. The previous papers are refs. 5 and 6.
rates of the interaction of a sterol-SCP complex with microsomal enzymes, properties of the protomer (16, (4) (5) (6) (7) (8) . SCP of highest purity was obtained by aggregation of protomer-SCP in the presence of sterol and phospholipid, followed by isolation of the oligomer (lipid* SCP complex) with a column of Sephadex G-75 (see conditions of Table 3 ). Formation of cholesta-5,7-dienol from cholest-7-enol by A7-sterol-A5-dehydrogenase (EC 1.3.3.x) was assayed by ultraviolet spectral analysis or the epiperoxide derivative procedure; the amount of cholesterol synthesized from cholesterol precursors was determined by passage of sterols through the dibromide derivative (4). For some experiments (e.g., Table 2 ) isotopically labeled sterols were separated on silicic acid-Super Cel columns with benzene as eluting agent (12) . Organic and phospholipid phosphorus was measured by the method of Bartlett (13) . Gel electrophoresis of SCP preparations was done in 0.1% sodium dodecyl sulfate (SDS) on 10% acrylamide as described by Weber and Osborn (14) . Sterol Table 2 ) or was totally removed by the purification procedure, and extra washings were not required (see Table  4 ). These findings ( of similar studies with various other cholesterol precursors established that in all cases the conversion of a precursor * SCP complex to cholesterol or other sterols is increased 2-fold or more over that of initially unbound precursor. In this regard, the absolute dependency on SCP for detectable enzymic activity was just described (e.g., Table 1 ). The probable explanation for the increased conversion rate to products of a precursor SCP complex is given by data obtained with a cholest-7-enol * SCP complex. The apparent Km for the enzymic conversion of cholest-7-enol SCP to cholesta-5,7-dienol SCP was 10 JAM at a ratio of SCP protein to enzyme protein of 10.2/1 (the optimum ratio for this reaction); at a suboptimal protein ratio (5.1/1), the apparent Km for substrate was 30 JAM. At both ratios of SCP to enzyme protein, the maximum rate of the reaction was not markedly changed. These results indicate that the microsomal enzymes have a high affinity for a preformed sterol * SCP complex (the oligomer) that participates at the active site of each enzyme.
Properties of the Protomer of SCP. Heat treatment at high ionic strength causes dissociation of the oligomer of SCP to a low molecular weight protein (protomer-SCP) and loss of associated sterol (5-8). As indicated in Fig. 1 , the apparent molecular weight of protomer-SCP determined by gel filtration and SDS gel electrophoresis is 16,000. Protomer-SCP migrates as a single band during SDS gel electrophoresis; a protein with the same mobility as protomer-SCP is present in unpurified SCP (Fig. 2) . During preparation of protomer-SCP, we observe small amounts of aggregates (30,000-60,000 daltons) of protomer-SCP (see Fig. 1B of ref. 6 ). These aggregates do not contain bound sterols and are most probably the SCP preparations obtained in the absence of heat treatment at high ionic strength by Scallen et al. (17) .
Spectral analysis of protomer-SCP revealed no measurable absorbance in the visible region (350-500 nm); in the ultraviolet region, protomer-SCP has a characteristic A280/ A260 of 0.68. The relatively high absorbance of protomer-SCP at 260 nm may be due to nucleotide contamination, e.g., we reported previously that SCP binds pyridine nucleotide as well as sterols (6) . Nucleotide contamination may also contribute to the amount of organic phosphorus (100-300 nmol/mg protein) present in protomer-SCP preparations (Table 3) . A typical unpurified SCP preparation contains Influence of Phospholipid on Aggregation and Purification of SCP. The functional similarities of one of the human plasma lipoprotein peptides and human liver-SCP are now well characterized (6, 18) . These findings led us to investigate possible additional similarities between plasma lipoproteins and SCP, in particular the interaction of SCP with phospholipids. During these studies we made the striking observation that phospholipid facilitated aggregation of protomer-SCP and sterol binding. The presence of lecithin resulted in a 4-fold increase in oligomer formation accompanied by a similar increase in bound sterol and organic phosphorus (Table 3) . It is probable that some of the organic phosphorus present in the sterol SCP complex formed in the presence of lecithin represents bound lecithin; at present this point has not been rigorously established. The influence of phospholipid on aggregation and sterol binding of protomer-SCP was used to obtain a 720-fold purification of the sterol SCP complex in 62% yield, based on activation of microsomal A'-dehydrogenase ( Table 4 ). The latter preparation of SCP may be of ultimate purity, i.e., the sterol-SCP complex elutes in the void volume of a Sephadex G-75 column and is thus widely separated from protomer-SCP (see Fig. 1C of ref. 6) .
Binding of Biologically Important Lipids Other Than Sterols to SCP. We reported previously that cholesterol, its waterinsoluble precursors, ,3-sitosterol, and hydroxy-derivatives of cholestane (in particular, 3j3, 5a, 6t3-cholestanetriol) bind to SCP; bile acids, steroid hormones, cholestane, and ketoderivatives of cholestane (not cholesterol precursors) are not bound or poorly bound to SCP (5) (6) (7) (8) . Additional studies (Table 5) (19) , lysozyme (20) , and ribonuclease (21); a cleft may also be present in the recently discovered retinol-binding protein (22) . Upon specific interaction of a cholesterol precursor * SCP complex with a microsomal enzyme a conformational change would occur, followed by the catalytic step and transfer of the sterol -SCP complex to the next microsomal enzyme. This hypothesis is in accord with our findings that a sterol present in a sterol SCP complex is more readily available to the catalytic site of a microsomal enzyme (Table 2) and that inhibitors of specific steps in cholesterol biosynthesis block formation of the activated conformation of a sterol-SCP * enzyme (complex (e.g., refs. 7 and 23).
